SAR - PPL Therapeutics PLC
26 Juin 2003 - 7:34PM
UK Regulatory
RNS Number:8526M
Metage Capital Limited
26 June 2003
FORM SAR 3
Lodge with a RIS or Newstrack and the Takeover Panel. A copy must also be sent
to the company the shares of which are acquired.
Date of disclosure...26/06/03
DISCLOSURE UNDER RULE 3 OF THE RULES GOVERNING SUBSTANTIAL ACQUISITIONS OF
SHARES ("SARs")
Date of acquisition 26th June 2003
Acquisition in PPL Therapeutics plc (name of company)
(1) Class of voting shares Number of shares/rights over shares If rights over shares acquired,
(eg ordinary shares) acquired as opposed to the shares
themselves, specify nature of
rights
ordinary shares 11,430,500 shares ...............................
No rights
(2) Resultant total holding of Resultant total holding of rights Total percentage
voting shares (and % of total over shares (and % of total voting
voting shares in issue) shares in issue)
24,409,610 (20.59%) ............................( %) .........................(%)
(3) Party making disclosure
Metage Capital Limited
(4) (a) Name of person acquiring shares or rights over shares
Metage Funds Limited
and, if different, beneficial owner ..............................
(b) Names of any other persons acting by
agreement or understanding (see SAR 5) .............................
Signed, for and on behalf of the party named in (3) above
Daron Sheehan
Telephone and extension number
0207 318 5273
______________________________________
Note. Under SAR 5, the holdings of and acquisitions by persons acting by
agreement or understanding must be aggregated and treated as a holding of or
acquisition by one person. Note 3 on SAR 5 requires persons who must aggregate
holdings to disclose certain disposals.
For full details of the SARs disclosure requirements, see Rules 3 and 5 of the
SARs. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring
Section, Tel. No: 020 7638 0129.
E-mail: monitoring@disclosure.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
SADILFFDRTIRFIV